a
a
a
Color scheme:
a a

Cancer Research Institute's Clinic

The clinic of the Cancer Research Institute provides multidisciplinary care and high-tech cancer treatment for patients living in Siberia and Russian Far East. It is a 220 bedded hospital with state of the art facilities for the diagnosis and treatment of cancer. Annually, 3.5 thousand patients receive cutting-edge therapies and image-guided interventions.

Clinical Departments:

  • Anesthesiology and Intensive Care
  • Chemotherapy
  • Diagnostic Imaging
  • Radiation oncology
  • Nuclear Medicine
  • Endoscopy
  • Outpatient Diagnostic Center
  • Hospital-Based Cancer Registry
  • Pharmacy
Surgical oncology:
  • Head & Neck Cancer Unit
  • Breast Cancer Unit
  • Bone and Soft Tissue Cancer Unit
  • Urologic Cancer Unit
  • Gastrointestinal Cancer Unit
  • Thoracic Cancer Unit
  • Gynecological Cancer Unit
Major fundamental research interests are:
  • To study cancer incidence, cancer-based morbidity and mortality in different ethnic populations on the territory of Siberia and the Russian Far East
  • To reveal endogenous and exogenous etiological factors and their complexes to improve organization of cancer care for the population of the region
  • To discover genetic and other molecular changes in tumor and tumor microenvironment to determine their role in clinical behavior and establish new molecular diagnostics and novel molecular therapeutic targets in cancer.
  • To study molecular mechanisms of breast cancer metastasis based on Lyden's metaststic niche concept and Paget "seed and soil" hypothesis as a platform for metastatic disease prediction and prevention.
  • To develop molecular diagnostic assays for routine clinical use in oncology practice.
  • To characterize mechanisms of resistance to therapies by integrating molecular profiling and functional genomics.
  • To promote rapid translation of basic discoveries of cancer mechanisms into the development of potential prognostic markers and therapeutic strategies.
  • To develop the most effective, safe, and cost-effective approaches for predictive, preventive and personalized oncology.

Results obtained from fundamental researches are translated into clinical applications.